Literature DB >> 32502555

Development of high-throughput screening assays for profiling snake venom phospholipase A2 activity after chromatographic fractionation.

Kristina B M Still1, Julien Slagboom1, Sarah Kidwai2, Chunfang Xie1, Yumei Zhao3, Bastiaan Eisses2, Zhengjin Jiang3, Freek J Vonk4, Govert W Somsen1, Nicholas R Casewell5, Jeroen Kool6.   

Abstract

Many organisms, ranging from plants to mammals, contain phospholipase A2 enzymes (PLA2s), which catalyze the production of lysophospholipids and fatty acid proinflammatory mediators. PLA2s are also common constituents of animal venoms, including bees, scorpions and snakes, and they cause a wide variety of toxic effects including neuro-, myo-, cyto-, and cardio-toxicity, anticoagulation and edema. The aim of this study was to develop a generic method for profiling enzymatically active PLA2s in snake venoms after chromatographic separation. For this, low-volume high-throughput assays for assessment of enzymatic PLA2 activity were evaluated and optimized. Subsequently, the assays were incorporated into a nanofractionation platform that combines high-resolution fractionation of crude venoms by liquid chromatography (LC) with bioassaying in 384-well plate format, and parallel mass spectrometric (MS) detection for toxin identification. The miniaturized assays developed are based on absorbance or fluorescence detection (respectively, using cresol red or fluorescein as pH indicators) to monitor the pH drop associated with free fatty acid formation by enzymatically active PLA2s. The methodology was demonstrated for assessment of PLA2 activity profiles of venoms from the snake species Bothrops asper, Echis carinatus, Echis coloratus, Echis ocellatus, Oxyuranus scutellatus and Daboia russelii russelii.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32502555     DOI: 10.1016/j.toxicon.2020.05.022

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib.

Authors:  Taline D Kazandjian; Arif Arrahman; Kristina B M Still; Govert W Somsen; Freek J Vonk; Nicholas R Casewell; Mark C Wilkinson; Jeroen Kool
Journal:  Toxins (Basel)       Date:  2021-04-23       Impact factor: 4.546

2.  A Spider Toxin Exemplifies the Promises and Pitfalls of Cell-Free Protein Production for Venom Biodiscovery.

Authors:  Tim Lüddecke; Anne Paas; Lea Talmann; Kim N Kirchhoff; Björn M von Reumont; André Billion; Thomas Timm; Günter Lochnit; Andreas Vilcinskas
Journal:  Toxins (Basel)       Date:  2021-08-18       Impact factor: 4.546

3.  Physiological constraints dictate toxin spatial heterogeneity in snake venom glands.

Authors:  Taline D Kazandjian; Brett R Hamilton; Samuel D Robinson; Steven R Hall; Keirah E Bartlett; Paul Rowley; Mark C Wilkinson; Nicholas R Casewell; Eivind A B Undheim
Journal:  BMC Biol       Date:  2022-06-27       Impact factor: 7.364

4.  Varespladib Inhibits the Phospholipase A2 and Coagulopathic Activities of Venom Components from Hemotoxic Snakes.

Authors:  Chunfang Xie; Laura-Oana Albulescu; Kristina B M Still; Julien Slagboom; Yumei Zhao; Zhengjin Jiang; Govert W Somsen; Freek J Vonk; Nicholas R Casewell; Jeroen Kool
Journal:  Biomedicines       Date:  2020-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.